National Advertising Division Finds Certain DUPIXENT Claims Supported; Recommends Sanofi Modify or Discontinue Other Claims
New York, NY – August 5, 2026 – Following a challenge brought by Galderma Laboratories, L.P., BBB National Programs’ National…